ArticleInternational medical case reports journal2013

Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya.

Fredrick Owino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.